ArticleBMC health services research2025

Cost-effectiveness and public health impact of recombinant zoster vaccine versus no herpes zoster vaccination in selected populations of immunocompromised adults in Canada.

Sydney George et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.